Cargando…

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers

OBJECTIVE: Unlike for patients with other forms of cardiomyopathies, those with severe ventricular dysfunction due to Duchenne muscular dystrophy (DMD) are not offered implantable cardioverter-defibrillator (ICD) therapy routinely. This prospective study aimed to determine the views of DMD-patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiermeier, Ursula M, Baker, Christine, Bourke, John P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Cardiomyopathies & Heart Failure
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204554/ https://www.ncbi.nlm.nih.gov/pubmed/32399251 http://dx.doi.org/10.1136/openhrt-2019-001230

Ejemplares similares

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Implantable cardioverter defibrillator deactivation and advance care planning: a focus group study
por: Stoevelaar, Rik, et al.
Publicado: (2020)

Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%
por: Wasfy, Jason H, et al.
Publicado: (2023)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
por: Roger-Rollé, Aénora, et al.
Publicado: (2020)

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
por: Woods, B, et al.
Publicado: (2015)

Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
por: Prameswari, Hawani Sasmaya, et al.
Publicado: (2023)

Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis
por: Yasuda, Masakazu, et al.
Publicado: (2016)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Five-year outcomes following left ventricular assist device implantation in England
por: Bottle, Alex, et al.
Publicado: (2021)

Timing of pacemaker and ICD implantation in LMNA mutation carriers
por: Ollila, Laura Helena, et al.
Publicado: (2021)

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease
por: El Sayed, Mohamed, et al.
Publicado: (2021)

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
por: Prior, David L, et al.
Publicado: (2015)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients
por: McCoy, Jodi, et al.
Publicado: (2017)

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
por: Agha, Ali M, et al.
Publicado: (2018)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Prognostic importance of the Controlling Nutritional Status (CONUT) score in patients undergoing cardiac resynchronisation therapy
por: Ikeya, Yukitoshi, et al.
Publicado: (2021)

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Update in imaging of cancer therapy-related cardiac toxicity in adults
por: de Baat, Esmée C, et al.
Publicado: (2021)

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis
por: Schrutka, Lore, et al.
Publicado: (2022)

Functional, morphological and electrocardiographical abnormalities in patients with apical hypertrophic cardiomyopathy and apical aneurysm: correlation with cardiac MR
por: Suwa, Kenichiro, et al.
Publicado: (2014)

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study
por: Narayan, Hari K, et al.
Publicado: (2017)

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis
por: Brun, Stéphanie, et al.
Publicado: (2019)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation
por: Moriyama, Shohei, et al.
Publicado: (2022)

Does recovery from submaximal exercise predict response to cardiac resynchronisation therapy?
por: Wouters, Philippe, et al.
Publicado: (2022)

Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection
por: Giang M, Nhat, et al.
Publicado: (2023)

Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
por: Aurich, Matthias, et al.
Publicado: (2023)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
por: Captur, Gabriella, et al.
Publicado: (2018)

Smoking intensity and duration is associated with cardiac structure and function: the ECHOcardiographic Study of Hispanics/Latinos
por: Leigh, J Adam, et al.
Publicado: (2017)

Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea
por: Berge, Kristian, et al.
Publicado: (2022)

Cardiac microstructural alterations measured by echocardiography identify sex-specific risk for heart failure
por: Kwan, Alan, et al.
Publicado: (2022)

Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure
por: Matsuo, Yae, et al.
Publicado: (2016)

Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Mustafa, Usman, et al.
Publicado: (2019)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
por: Spurney, Christopher F, et al.
Publicado: (2021)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p284mj5hbjps4j3o158vs7ubcc